SKI knockdown inhibits human melanoma tumor growth in vivo

Pigment Cell and Melanoma Research

Volumn 22, Issue 6, 2009, Pages 761-772

  Chen, Dahu ^a   Lin, Qiushi ^a   Box, Neil ^b   Roop, Dennis ^b   Ishii, Shunsuke ^c   Matsuzaki, Koichi ^d   Fan, Tao ^e   Hornyak, Thomas J ^e   Reed, Jon A ^b   Stavnezer, Ed ^f   Timchenko, Nikolai A ^a,b   Medrano, Estela E ^a,b  

^a Huffington Center on Aging   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c RIKEN TSUKUBA INSTITUTE   (Japan)

^d KANSAI MEDICAL UNIVERSITY   (Japan)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

^f CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

C MYC; Melanoma; PAI 1; SKI, TGF ; Smad3 linker phosphorylation

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; MYC PROTEIN; ONCOPROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN SKI; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADULT; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MELANOCYTE; MELANOMA CELL; MITOSIS; MOUSE; NEWBORN; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR XENOGRAFT; UPREGULATION;

ANIMALS; DNA-BINDING PROTEINS; GENE KNOCKDOWN TECHNIQUES; HUMANS; MALE; MELANOMA; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; PHOSPHORYLATION; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 70350102906     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1755-148X.2009.00603.x     Document Type: Article

References (70)

1. Akiyoshi, S., Inoue, H., Hanai, J., Kusanagi, K., Nemoto, N., Miyazono, K. Kawabata, M. (1999). c-Ski acts as a transcriptional co-repressor in transforming growth factor-beta signaling through interaction with smads. J. Biol. Chem. 274, 35269 35277.
2. Andreasen, P.A. (2007). PAI-1 - a potential therapeutic target in cancer. Curr. Drug Targets 8, 1030 1041.
3. Bajou, K., Peng, H., Laug, W.E., Maillard, C., Noel, A., Foidart, J.M., Martial, J.A. DeClerck, Y.A. (2008). Plasminogen activator inhibitor-1 protects endothelial cells from FasL-mediated apoptosis. Cancer Cell 14, 324 334.
4. Bandyopadhyay, D., Curry, J.L., Lin, Q., Richards, H.W., Chen, D., Hornsby, P.J., Timchenko, N.A. Medrano, E.E. (2007). Dynamic assembly of chromatin complexes during cellular senescence: implications for the growth arrest of human melanocytic nevi. Aging Cell 6, 577 591.
5. Berking, C., Takemoto, R., Schaider, H., Showe, L., Satyamoorthy, K., Robbins, P. Herlyn, M. (2001). Transforming growth factor-beta1 increases survival of human melanoma through stroma remodeling. Cancer Res. 61, 8306 8316.
6. Boone, B., Haspeslagh, M. Brochez, L. (2009). Clinical significance of the expression of c-Ski and SnoN, possible mediators in TGF-beta resistance, in primary cutaneous melanoma. J. Dermatol. Sci. 53, 26 33.
7. Bruna, A., Darken, R.S., Rojo, F. et al. (2007). High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene. Cancer Cell 11, 147 160.
8. Chen, D., Xu, W., Bales, E. et al. (2003). SKI activates Wnt/beta-catenin signaling in human melanoma. Cancer Res. 63, 6626 6634.
9. Chen, W., Lam, S.S., Srinath, H., Schiffer, C.A., Royer, W.E. Jr. Lin, K. (2007). Competition between Ski and CREB-binding protein for binding to Smad proteins in transforming growth factor-beta signaling. J. Biol. Chem. 282, 11365 11376.
10. Colmenares, C., Sutrave, P., Hughes, S.H. Stavnezer, E. (1991). Activation of the c-ski oncogene by overexpression. J. Virol. 65, 4929 4935.
11. Dumont, N. Arteaga, C.L. (2003). Targeting the TGF beta signaling network in human neoplasia. Cancer Cell 3, 531 536.
12. Eilers, M. Eisenman, R.N. (2008). Myc's broad reach. Genes Dev. 22, 2755 2766.
13. Engel, M.E., McDonnell, M.A., Law, B.K. Moses, H.L. (1999). Interdependent SMAD and JNK signaling in transforming growth factor-beta-mediated transcription. J. Biol. Chem. 274, 37413 37420.
14. Fukuchi, M., Nakajima, M., Fukai, Y., Miyazaki, T., Masuda, N., Sohda, M., Manda, R., Tsukada, K., Kato, H. Kuwano, H. (2004). Increased expression of c-Ski as a co-repressor in transforming growth factor-beta signaling correlates with progression of esophageal squamous cell carcinoma. Int. J. Cancer 108, 818 824.
15. Garcia, M., Fernandez-Garcia, N.I., Rivas, V. et al. (2004). Inhibition of xenografted human melanoma growth and prevention of metastasis development by dual antiangiogenic/antitumor activities of pigment epithelium-derived factor. Cancer Res. 64, 5632 5642.
16. Groppe, J., Hinck, C.S., Samavarchi-Tehrani, P., Zubieta, C., Schuermann, J.P., Taylor, A.B., Schwarz, P.M., Wrana, J.L. Hinck, A.P. (2008). Cooperative assembly of TGF-beta superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding. Mol. Cell 29, 157 168.
17. Haluska, F.G., Tsao, H., Wu, H., Haluska, F.S., Lazar, A. Goel, V. (2006). Genetic alterations in signaling pathways in melanoma. Clin. Cancer Res. 12, 2301s 2307s.
18. Hanahan, D. Weinberg, R.A. (2000). The hallmarks of cancer. Cell 100, 57 70.
19. Heider, T.R., Lyman, S., Schoonhoven, R. Behrns, K.E. (2007). Ski promotes tumor growth through abrogation of transforming growth factor-beta signaling in pancreatic cancer. Ann. Surg. 246, 61 68.
20. Herlyn, M. Shih, I.M. (1994). Interactions of melanocytes and melanoma cells with the microenvironment. Pigment Cell Res. 7, 81 88.
21. Hoek, K.S., Schlegel, N.C., Brafford, P. et al. (2006). Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. Pigment Cell Res. 19, 290 302.
22. Jacob, C., Grabner, H., Atanasoski, S. Suter, U. (2008). Expression and localization of Ski determine cell type-specific TGFbeta signaling effects on the cell cycle. J. Cell Biol. 182, 519 530.
23. Javelaud, D., Alexaki, V.I. Mauviel, A. (2008). Transforming growth factor-beta in cutaneous melanoma. Pigment Cell Melanoma Res 21, 123 132.
24. Kokura, K., Kim, H., Shinagawa, T., Khan, M.M., Nomura, T. Ishii, S. (2003). The Ski-binding protein C184M negatively regulates tumor growth factor-beta signaling by sequestering the Smad proteins in the cytoplasm. J. Biol. Chem. 278, 20133 20139.
25. Krasagakis, K., Garbe, C. Orfanos, C.E. (1993). Cytokines in human melanoma cells: synthesis, autocrine stimulation and regulatory functions - an overview. Melanoma Res. 3, 425 433.
26. Krasagakis, K., Garbe, C., Zouboulis, C.C. Orfanos, C.E. (1995). Growth control of melanoma cells and melanocytes by cytokines. Recent Results Cancer Res. 139, 169 182.
27. Krasagakis, K., Kruger-Krasagakes, S., Fimmel, S., Eberle, J., Tholke, D., von der, O.M., Mansmann, U. Orfanos, C.E. (1999). Desensitization of melanoma cells to autocrine TGF-beta isoforms. J. Cell. Physiol. 178, 179 187.
28. Le Scolan, E., Zhu, Q., Wang, L., Bandyopadhyay, A., Javelaud, D., Mauviel, A., Sun, L. Luo, K. (2008). Transforming growth factor-beta suppresses the ability of Ski to inhibit tumor metastasis by inducing its degradation. Cancer Res. 68, 3277 3285.
29. Li, A.G., Lu, S.L., Zhang, M.X., Deng, C. Wang, X.J. (2004). Smad3 knockout mice exhibit a resistance to skin chemical carcinogenesis. Cancer Res. 64, 7836 7845.
30. Lin, X., Duan, X., Liang, Y.Y. et al. (2006). PPM1A functions as a Smad phosphatase to terminate TGFbeta signaling. Cell 125, 915 928.
31. Longerich, T., Breuhahn, K., Odenthal, M., Petmecky, K. Schirmacher, P. (2004). Factors of transforming growth factor beta signalling are co-regulated in human hepatocellular carcinoma. Virchows Arch. 445, 589 596.
32. Lopez-Bergami, P., Huang, C., Goydos, J.S. et al. (2007). Rewired ERK-JNK signaling pathways in melanoma. Cancer Cell 11, 447 460.
33. Luo, K., Stroschein, S.L., Wang, W., Chen, D., Martens, E., Zhou, S. Zhou, Q. (1999). The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling. Genes Dev. 13, 2196 2206.
34. MacDougall, J., Kobayashi, H. Kerbel, R.S. (1993). Responsiveness of normal, dysplastic melanocytes, and melanoma cells from different lesional stages of disease progression to the growth inhibitory effects of TGF-beta. Mol. Cell. Differ. 1, 21 40.
35. Massague, J. Gomis, R.R. (2006). The logic of TGFbeta signaling. FEBS Lett. 580, 2811 2820.
36. Matsuzaki, K. (2006). Smad3 phosphoisoform-mediated signaling during sporadic human colorectal carcinogenesis. Histol. Histopathol. 21, 645 662.
37. Matsuzaki, K., Kitano, C., Murata, M., Sekimoto, G., Yoshida, K., Uemura, Y., Seki, T., Taketani, S., Fujisawa, J.I. Okazaki, K 2009). Smad2 and smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-{beta} signal in later stages of human colorectal cancer. Cancer Res Jun 16. [Epub ahead of print] PMID: 19531654.
38. McMahon, G.A., Petitclerc, E., Stefansson, S., Smith, E., Wong, M.K., Westrick, R.J., Ginsburg, D., Brooks, P.C. Lawrence, D.A. (2001). Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis. J. Biol. Chem. 276, 33964 33968.
39. Medrano, E.E. (2003). Repression of TGF-beta signaling by the oncogenic protein SKI in human melanomas: consequences for proliferation, survival, and metastasis. Oncogene 22, 3123 3129.
40. Miyazono, K., Suzuki, H. Imamura, T. (2003). Regulation of TGF-beta signaling and its roles in progression of tumors. Cancer Sci. 94, 230 234.
41. Mizuide, M., Hara, T., Furuya, T., Takeda, M., Kusanagi, K., Inada, Y., Mori, M., Imamura, T., Miyazawa, K. Miyazono, K. (2003). Two short segments of Smad3 are important for specific interaction of Smad3 with c-Ski and SnoN. J. Biol. Chem. 278, 531 536.
42. Muthusamy, V., Hobbs, C., Nogueira, C., Cordon-Cardo, C., McKee, P.H., Chin, L. Bosenberg, M.W. (2006). Amplification of CDK4 and MDM2 in malignant melanoma. Genes Chromosomes. Cancer 45, 447 454.
43. Pardali, K. Moustakas, A. (2007). Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer. Biochim. Biophys. Acta 1775, 21 62.
44. Reed, J.A., McNutt, N.S., Prieto, V.G. Albino, A.P. (1994). Expression of transforming growth factor-beta 2 in malignant melanoma correlates with the depth of tumor invasion. Implications for tumor progression. Am. J. Pathol. 145, 97 104.
45. Reed, J.A., Bales, E., Xu, W., Okan, N.A., Bandyopadhyay, D. Medrano, E.E. (2001). Cytoplasmic localization of the oncogenic protein ski in human cutaneous melanomas in vivo: functional implications for transforming growth factor Beta signaling. Cancer Res. 61, 8074 8078.
46. Rodeck, U., Bossler, A., Graeven, U., Fox, F.E., Nowell, P.C., Knabbe, C. Kari, C. (1994). Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cells. Cancer Res. 54, 575 581.
47. Rodeck, U., Nishiyama, T. Mauviel, A. (1999). Independent regulation of growth and SMAD-mediated transcription by transforming growth factor beta in human melanoma cells. Cancer Res. 59, 547 550.
48. Sapkota, G., Knockaert, M., Alarcon, C., Montalvo, E., Brivanlou, A.H. Massague, J. (2006). Dephosphorylation of the linker regions of Smad1 and Smad2/3 by small C-terminal domain phosphatases has distinct outcomes for bone morphogenetic protein and transforming growth factor-beta pathways. J. Biol. Chem. 281, 40412 40419.
49. Satyamoorthy, K., Li, G., Gerrero, M.R., Brose, M.S., Volpe, P., Weber, B.L., Van Belle, P., Elder, D.E. Herlyn, M. (2003). Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation. Cancer Res. 63, 756 759.
50. Schmid, P., Itin, P. Rufli, T. (1995). In situ analysis of transforming growth factor-beta s (TGF-beta 1, TGF-beta 2, TGF-beta 3), and TGF-beta type II receptor expression in malignant melanoma. Carcinogenesis 16, 1499 1503.
51. Sekimoto, G., Matsuzaki, K., Yoshida, K., Mori, S., Murata, M., Seki, T., Matsui, H., Fujisawa, J. Okazaki, K. (2007). Reversible smad-dependent signaling between tumor suppression and oncogenesis. Cancer Res. 67, 5090 5096.
52. Seoane, J., Le, H.V., Shen, L., Anderson, S.A. Massague, J. (2004). Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell 117, 211 223.
53. Shinagawa, T. Ishii, S. (2003). Generation of Ski-knockdown mice by expressing a long double-strand RNA from an RNA polymerase II promoter. Genes Dev. 17, 1340 1345.
54. Shinagawa, T., Nomura, T., Colmenares, C., Ohira, M., Nakagawara, A. Ishii, S. (2001). Increased susceptibility to tumorigenesis of ski-deficient heterozygous mice. Oncogene 20, 8100 8108.
55. Siegel, P.M. Massague, J 2008). Growth control by TGF-β: mechanisms controlling cell cycle progression and apoptosis. In The TGF-β Family, R. Derynck K. Miyazono, eds Cold Spring Harbor New York : Cold Spring Harbor Laboratory Press pp. 333 362.
56. Sun, Y., Liu, X., Eaton, E.N., Lane, W.S., Lodish, H.F. Weinberg, R.A. (1999a). Interaction of the Ski oncoprotein with Smad3 regulates TGF-beta signaling. Mol. Cell 4, 499 509.
57. Sun, Y., Liu, X., Ng-Eaton, E., Lodish, H.F. Weinberg, R.A. (1999b). SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor beta signaling. Proc. Natl. Acad. Sci. USA 96, 12442 12447.
58. Tabata, T., Kokura, K., ten Dijke, P. Ishii, S. (2009). Ski co-repressor complexes maintain the basal repressed state of the TGF-beta target gene, SMAD7, via HDAC3 and PRMT5. Genes Cells 14, 17 28.
59. Takahata, M., Inoue, Y., Tsuda, H. et al. (2009). SKI and MEL1 cooperate to inhibit transforming growth factor-beta signal in gastric cancer cells. J. Biol. Chem. 284, 3334 3344.
60. Teichler, S., Schlenk, R.F., Strauch, K., Hagner, N.M., Ritter, M. Neubauer, A. (2008). Expression of the nuclear oncogene Ski in patients with acute myeloid leukemia treated with all-trans retinoic acid. Haematologica 93, 1105 1107.
61. Ueki, N. Hayman, M.J. (2003). Direct interaction of Ski with either Smad3 or Smad4 is necessary and sufficient for Ski-mediated repression of transforming growth factor-beta signaling. J. Biol. Chem. 278, 32489 32492.
62. Wang, H., Mannava, S., Grachtchouk, V., Zhuang, D., Soengas, M.S., Gudkov, A.V., Prochownik, E.V. Nikiforov, M.A. (2008). c-Myc depletion inhibits proliferation of human tumor cells at various stages of the cell cycle. Oncogene 27, 1905 1915.
63. Wang, G., Matsuura, I., He, D. Liu, F. (2009). Transforming growth factor-{beta}-inducible phosphorylation of Smad3. J. Biol. Chem. 284, 9663 9673.
64. Watson, J.D., Oster, S.K., Shago, M., Khosravi, F. Penn, L.Z. (2002). Identifying genes regulated in a Myc-dependent manner. J. Biol. Chem. 277, 36921 36930.
65. Wrighton, K.H., Willis, D., Long, J., Liu, F., Lin, X. Feng, X.H. (2006). Small C-terminal domain phosphatases dephosphorylate the regulatory linker regions of Smad2 and Smad3 to enhance transforming growth factor-beta signaling. J. Biol. Chem. 281, 38365 38375.
66. Xu, W., Angelis, K., Danielpour, D., Haddad, M.M., Bischof, O., Campisi, J., Stavnezer, E. Medrano, E.E. (2000). Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor. Proc. Natl. Acad. Sci. USA 97, 5924 5929.
67. Yamagata, H., Matsuzaki, K., Mori, S. et al. (2005). Acceleration of Smad2 and Smad3 phosphorylation via c-Jun NH(2)-terminal kinase during human colorectal carcinogenesis. Cancer Res. 65, 157 165.
68. Yang, G., Li, Y., Nishimura, E.K., Xin, H., Zhou, A., Guo, Y., Dong, L., Denning, M.F., Nickoloff, B.J. Cui, R. (2008). Inhibition of PAX3 by TGF-beta modulates melanocyte viability. Mol. Cell 32, 554 563.
69. Zhang, H. Stavnezer, E. (2009). Ski regulates muscle terminal differentiation by transcriptional activation of Myog in a complex with Six1 and Eya3. J. Biol. Chem. 284, 2867 2879.
70. Zhuang, D., Mannava, S., Grachtchouk, V. et al. (2008). C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells. Oncogene 27, 6623 6634.